Xanthus Pharmaceuticals

About:

Xanthus is a biopharmaceutical company.

Top Investors: Oxford Bioscience Partners, Gimv, HealthCare Ventures, Kester Capital, Neomed Management

Description:

Xanthus Pharmaceuticals Inc. operates as a biopharmaceutical company. It focuses on the discovery, development, acquisition, and commercialization of small-molecule therapeutics for the treatment of cancer and autoimmune disorders.

Total Funding Amount:

$76.2M

Estimated Revenue Range:

Less than $1M

Headquarters Location:

Cambridge, Massachusetts, United States

Founded Date:

2001-01-01

Founders:

Number of Employees:

11-50

Last Funding Date:

2006-12-01

IPO Status:

Private

Industries: